Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
3
50%
Ph phase_2
2
33%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
Phase 31 (16.7%)

Trials by Status

not_yet_recruiting117%
terminated117%
completed467%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_2

Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis

NCT06917495
terminatedphase_2

Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

NCT04272242
completedphase_1

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

NCT01574638
completedphase_3

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

NCT01404312
completedphase_1

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

NCT02651259
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06917495Phase 2

Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis

Not Yet Recruiting
NCT04272242Phase 2

Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

Terminated
NCT01574638Phase 1

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

Completed
NCT01404312Phase 3

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

Completed
NCT02651259Phase 1

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

Completed
NCT03886701Phase 1

Doravirine, Rifapentine and Isoniazid Interaction

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6